Stock Value
Competitors
| Ticker | Price | Forecast 1Y | Forecast 2Y | Market Cap | Div Yld | Growth Rate |
|---|---|---|---|---|---|---|
|
NYSE:ABBV
AbbVie
|
159.61 | -19.77% | -9.16% | 281,850.16 | 3.81% | 7.03% |
|
NasdaqGS:AMGN
Amgen
|
309.41 | -11.4% | -2.52% | 165,978.26 | 2.86% | 5.31% |
|
NasdaqGS:GILD
Gilead Sciences Inc
|
67.80 | 20.75% | 30% | 84,468.85 | 4.58% | 0.15% |
|
NasdaqGM:ALXN
Alexion Pharmaceuticals
|
182.50 | 0% | 0% | 40,336.01 | 0% | 0% |
|
NasdaqGS:BIIB
Biogen
|
225.21 | -13.21% | 2.19% | 32,789.88 | 0% | -10.89% |
|
NasdaqGS:BMRN
BioMarin Pharmaceutical
|
76.45 | 154.97% | 238.58% | 14,615.05 | 0% | 32.46% |
|
NasdaqGS:INCY
Incyte
|
58.20 | 104.81% | 153.29% | 12,012.93 | 0% | 27.62% |
|
NasdaqCM:VKTX
Viking Therapeutics
|
63.01 | 0% | 0% | 8,843.51 | 0% | 0% |
|
NasdaqGS:BPMC
Blueprint Medicines
|
102.71 | 0% | 0% | 6,783.92 | 0% | 0% |
|
NasdaqGM:ARNA
Arena Pharmaceuticals
|
99.99 | 0% | 0% | 6,165.32 | 0% | 0% |
|
NasdaqGM:IOVA
Iovance Biotherapeutics
|
10.33 | 0% | 0% | 3,763.74 | 0% | 0% |
|
NasdaqGS:CCXI
ChemoCentryx
|
51.99 | 0% | 0% | 3,739.11 | 0% | 0% |
|
NasdaqGS:CBAY
CymaBay Therapeutics
|
32.44 | 0% | 0% | 3,724.47 | 0% | 0% |
|
NasdaqGS:ARWR
Arrowhead Pharmaceuticals
|
25.14 | 0% | 0% | 3,062.73 | 0% | 0% |
|
NasdaqGM:DRNA
Dicerna Pharmaceuticals
|
38.01 | 0% | 0% | 2,986.1 | 0% | 0% |
|
NasdaqGM:FOLD
Amicus Therapeutics
|
9.72 | 0% | 0% | 2,807.75 | 0% | 0% |
|
NasdaqCM:CLDX
Celldex Therapeutics
|
38.10 | 0% | 0% | 2,631.15 | 0% | 0% |
|
NasdaqGS:ACAD
ACADIA Pharmaceuticals
|
15.82 | 0% | 0% | 2,512.75 | 0% | 0% |
|
NasdaqGM:VCEL
Vericel
|
50.33 | -94.78% | -76.15% | 2,364.47 | 0% | 0% |
|
NasdaqGM:ADMA
ADMA Biologics
|
9.63 | 0% | 0% | 2,042.24 | 0% | 0% |
